Table 29:
Strategy | Average Total Cost, $ (95% Confidence Interval) | Incremental Cost, $a | Average Total Effect, QALYs (95% Confidence Interval) | Incremental Effect, QALYsb | ICER, $/QALY |
---|---|---|---|---|---|
Adults (Age 18–55 Years), Postlingual Severe to Profound Sensorineural Hearing Loss, Sequential BCI | |||||
UCI | 65,961 (58,974–73,738) | — | 23.28 (16.67–28.13) | — | — |
BCI sequential | 113,470 (98,345–127,795) | 47,509 (35,067–54,831) | 24.25 (18.12–28.55) | 0.97 (−6.67 to 8.17) | 48,978 |
Children, Prelingual Severe to Profound Sensorineural Hearing Loss, Simultaneous BCI | |||||
UCI | 88,848 (80,810–97,999) | — | 36.07 (31.48–39.88) | — | — |
BCI simultaneous | 156,319 (143,526–170,580) | 67,471 (61,527–73,799) | 38.53 (29.19–44.39) | 2.46 (−7.50 to 9.91) | 27,427 |
Children, Postlingual Severe to Profound Sensorineural Hearing Loss, Sequential BCI | |||||
UCI | 86,376 (78,429–95,389) | — | 34.61 (30.21–38.27) | — | — |
BCI sequential | 152,010 (137,794–167,120) | 65,634 (58,531–72,511) | 36.77 (28.49–42.09) | 2.16 (−6.69 to 8.84) | 30,386 |
Abbreviations: BCI, bilateral cochlear implant; ICER, incremental cost-effectiveness ratio; QALY quality-adjusted life-year; UCI, unilateral cochlear implant.
Incremental cost = average cost BCI – average cost UCI.
Incremental effect = average effect BCI – average effect UCI.